RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

Genetic technologies for hemophilia video series released

Genetic technologies for hemophilia video series released

The World Federation of Hemophilia (WFH) is pleased to announce the release of a new four-part educational video series on genetic technologies for hemophilia. Designed for people with bleeding disorders, their families, and healthcare professionals, the series explains complex scientific concepts in a clear and accessible way.

Also available in: Español

The video series provides an overview of the science behind hemophilia and explores three genetic technologies currently being used or studied: adeno-associated virus (AAV) gene therapy, lentiviral gene therapy, and gene editing. Using straightforward explanations and visual analogies, the videos explain how these approaches work, their potential benefits, and important considerations.

Genetic Technologies: The Basics

Learn how genes and DNA work, how hemophilia is caused, and the key differences between AAV gene therapy, lentiviral gene therapy, and gene editing.

Genetic Technologies: AAV Gene Therapy

An overview of AAV gene therapy for hemophilia, including how it works, who may be eligible, and its potential benefits and limitations.

Genetic Technologies: Lentiviral Gene Therapy

Discover how lentiviral gene therapy uses a person’s own blood stem cells to introduce a functional clotting factor gene and support long-term clotting factor production.

Genetic Technologies: Gene Editing

Learn how gene editing technologies such as CRISPR can precisely modify DNA and their potential as future treatments for hemophilia.

The videos are available in English, with French and Spanish subtitles.

The four-part educational video series on genetic technologies for hemophilia was exclusively supported by Regeneron.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.